ClinicalTrials.gg
RecruitingNCT06587607Updated Mar 2, 2026

VR Mindfulness Training for Veterans With SCI

An interventional study of VA Compassionate Awareness Learning Module (VA CALM) a mindfulness curriculum. in Spinal Cord Injury and Chronic Pain, sponsored by VA Office of Research and Development. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-02.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 76 studies in Spinal Cord Injuries by VA Office of Research and Development — 17 open to participants now, 18 under way, 1 of them phase 3. Spinal Cord Injuries · VA Office of Research and Development.

Planned enrollment
51st of 69
10 · median 20
Started
2025
with 1 other
No phase
52 of 76
14 open now
Primary completion
2027-06
later than 7 of 17 live
Registered
70th of 76
by date

Among the 76 studies in Spinal Cord Injuries by VA Office of Research and Development, this one is the 51st largest by planned enrollment of the 69 interventional ones that give a count, is one of 2 that started in 2025, is one of 52 with no phase, reaches primary completion later than 7 of the 17 other live ones, and was the 70th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

17 of the 76 studies in Spinal Cord Injuries by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:

11 more — sign in →

By country, each count listing its studies:

All 17 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 76 studies in Spinal Cord Injuries by VA Office of Research and Development, or all of them as a file.
02

Study summary

This study involves delivering a mindfulness program that was developed for Veterans called VA Compassionate Awareness Learning Module (VA CALM) to Veterans with spinal cord injuries (SCI) to develop accommodations to make the VA CALM program more accessible for those with SCI. It will involve delivering the unmodified curriculum to a group of Veterans with SCI first to determine what areas need accommodations, working with a group of stakeholders to develop appropriate accommodations, and then delivering 1-2 modified modules via virtual reality to evaluate whether using virtual reality was feasible and acceptable for this program.

Read the detailed description

The objectives of this study are to explore the feasibility and acceptability of a spinal cord injury (SCI) tailored, evidence-based mindfulness group known as VA Compassionate Awareness Learning Module (VA CALM) when delivered via virtual reality (VR) The project will first assess modification needs for SCI and then explore the feasibility and acceptability of delivering VA CALM-SCI over VR.

The long-term goals and significance of this study include studying the efficacy of VA CALM-SCI for the treatment of chronic pain and examining the comparative effectiveness between VR and video telehealth modalities to build evidence for the modified intervention. This work has the potential to improve care for Veterans with SCI who are at risk of being left out of innovative clinical advancements that improve quality of life and well-being, due to the complexity of their medical condition.

Aim 1: Conduct a formative evaluation of the VA CALM program to develop accommodations to improve program accessibility and acceptability for Veterans with SCI and chronic pain (VA CALM-SCI).

  • Aim 1a: Deliver the VA CALM program to 10 Veterans with SCI over telehealth to conduct a formative evaluation of the VA CALM curriculum to tailor for SCI contextual needs.
  • Aim 1b: Assemble a Steering Committee of SCI stakeholders (10 members) to develop appropriate strategies, accommodations, and recommended tools to support the delivery of VA CALM-SCI.

Aim 2: Explore the feasibility and acceptability of delivering VA CALM-SCI over a Virtual Reality platform for Veterans with SCI and chronic pain.

  • Aim 2a: Assess potential VR applications and settings for delivery and testing of VA CALM-SCI.
  • Aim 2b: Deliver 2 VA CALM-SCI modules over VR to Veterans with SCI to assess the feasibility and acceptability of using VR in this population to deliver mindfulness training.
03

Conditions studied

  • Spinal Cord Injury
  • Chronic Pain

Keywords

  • Spinal Cord Injuries
  • Chronic Pain
  • Virtual Reality
  • Mindfulness
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Veteran
  • Diagnosis of spinal cord injury with incomplete or complete tetraplegia based on AIS score OR incomplete or complete paraplegia based on AIS score.
  • Endorses chronic pain lasting 3 months;
  • age 18+ years
  • Access to high-speed internet
  • Endorse being (at least) minimally proficient on the computer (eg, able to check emails, read the news, etc.); be able, either independently or with caregiver support, to get online for virtual meetings and don/doff VR equipment
  • Able to speak clearly and independently to participate in focus group interviews.

Exclusion criteria

Exclusion Criteria:

-Individuals unable to consent for research or medical care are ineligible to participate.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    VA CALM

    This group will receive the VA CALM mindfulness programming.

    Behavioral: VA Compassionate Awareness Learning Module (VA CALM) a mindfulness curriculum.

Interventions

  • BehavioralVA Compassionate Awareness Learning Module (VA CALM) a mindfulness curriculum.

    VA CALM is a 9 week mindfulness curriculum typically delivered at a once/week module pace in group settings during sessions that last approximately 60-90 minutes. Module topics include: Program Introduction, Why mindfulness, Perception, What Makes Something a Pleasant Experience?, Being Stuck, Getting Unstuck, Communication, Mindfulness in Daily Life, and Today is the First Dat of the Rest of Your Life.

    Also known as: VA CALM

06

What researchers measure

Primary outcomes

  1. Mindfulness- Five Facet Mindfulness Questionnaire (FFMQ)

    Minimum Score: 1 Maximum Score: 5 Score Interpretation: Items are aggregated and averaged. Higher scores indicate greater mindfulness.

    Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).

  2. Pain- PROMIS-Pain Numeric Rating Scale (NRS)

    Minimum Score: 0 Maximum Score: 10 Score Interpretation: Single item measure, higher scores indicate greater pain intensity.

    Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).

  3. Mindfulness- Mindfulness Attention Awareness Scale (MAAS)

    Minimum Score: 1 Maximum Score: 6 Score Interpretation: Items are aggregated and averaged. Higher scores indicate greater mindfulness

    Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).

  4. Pain Interference- PROMIS-Pain Interference (PROMIS-PI, SF8a)

    Minimum Score: 8 Maximum Score: 40 Score Interpretation: Scores are converted into a T-score which rescales the score into a standardized score with a mean of 50 and a standard deviation of 10. Higher scores indicate greater pain interference.

    Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).

  5. Pain Acceptance- Chronic Pain Acceptance Questionnaire-Revised (CPAQ-R)

    Minimum Score: 0 Maximum Score: 6 Score Interpretation: Generates scores for two domains: Activity Engagement and Pain Willingness. Scores for each item in a domain are aggregated. Higher scores indicate higher levels of acceptance.

    Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).

  6. Pain Catastrophizing- Pain Catastrophizing Scale (PCS)

    Minimum Score: 0 Maximum Score: 52 Score Interpretation: Generates a total score PCS-T and three subscale scores: Rumination, Magnification, and Helplessness. Total score above 30 indicates clinically relevant level of catastrophizing.

    Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).

Secondary outcomes

  1. Quality of Life- World Health Organization Quality of Life-Brief (WHOQOL-BREF)

    Minimum Score: 4 Maximum Score: 20 Score interpretation: Measure is comprised of 4 quality of life domains: physical health, psychological health, social relationships, and environment. Items for each domain are aggregated, averaged, then scaled for final scoring. Higher scores indicate higher quality of life.

    Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).

  2. Anxiety- Generalized Anxiety Disorder (GAD-7)

    Minimum Score: 0 Maximum Score: 21 Score Interpretation: Higher scores indicate more severe anxiety. 0-4: minimal anxiety, 5-9: mild anxiety, 10-14: moderate anxiety, 15-21: severe anxiety.

    Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).

  3. Depression- Patient Health Questionnaire-9 (PHQ-9)

    Minimum Score: 0 Maximum Score: 27 Score Interpretation: Item scores are aggregated. Higher scores indicate greater depression severity. 0: no depression, 1-4: minimal depression, 5-9: mild depression, 10-14: moderate depression, 15-19: moderately severe depression, 20-27: severe depression.

    Time frame: Baseline to 2 weeks post completion (Approx 14 weeks).

  4. Virtual Reality Embodiment- One-Item Presence Scale

    Minimum Score: 1 Maximum Score: 10 Score Interpretation: Single item. Higher score indicates greater virtual presence.

    Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).

  5. Virtual Reality Embodiment- Virtual Embodiment Questionnaire

    Minimum Score:1 Maximum Score: 7 Scoring interpretation: Measures 3 domains: Acceptance (ownership), Control (agency), and Change (perceived change in the body scheme). Item scores are aggregated then averaged for each domain. Higher scores indicate greater embodiment.

    Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).

  6. Acceptability of Virtual Reality- System Usability Scale (SUS)

    Minimum Score: 0 Maximum Score: 100 Score interpretation: Items aggregated. Higher scores indicate greater usability.

    Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).

  7. Acceptability of Virtual Reality- Standardized User Experience Percentile Rank Questionnaire (SUPRQ)

    Raw component Minimum Score: 1 Raw component Maximum Score: 5 Percentile Minimum Score: 0 Percentile Minimum Score: 100 Score interpretation: Two scores are generated and evaluated: Raw component score (1-5) which is aggregated and then averaged and percentile score (0-100). Higher scores indicate better user experience for both scales.

    Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).

  8. Acceptability of Program- Acceptability of Intervention Measure (AIM)

    Minimum Score: 1 Maximum Score: 5 Score interpretation: Items aggregated then averaged. Higher scores indicate greater acceptability.

    Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).

  9. Acceptability of Program- Intervention Appropriateness Measure (IAM)

    Minimum Score: 1 Maximum Score: 5 Score interpretation: Items aggregated then averaged. Higher scores indicate greater appropriateness.

    Time frame: After completion of 2nd VR session (One time point at completion of study, approximately week 12).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in articles to be published after de-identification (text, tables, figures, and appendices) as required by publishers, funding agencies, and or by law. Further, a Limited Dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset.

Supporting information: Study protocol

Time frame: Beginning 3 months and ending 36 months following article publication.

Access criteria: Data sharing will be permitted for the purposes of validation of results via replication of analyses with the limited, de-identified database. Individually identifiable information will be removed from any database shared to ensure protection of personal privacy. Further the data will be shared pursuant to a data use agreement which prohibits re-identification.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Jun 2027, 23 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 23 months is below that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 4, 2024
First posted
Sep 19, 2024
StartActual
Jul 1, 2025
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jun 30, 2027
Last update
Mar 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06587607
Responsible party
Sponsor
First posted
Sep 19, 2024
Start date
Jul 1, 2025
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Mar 2, 2026

Study contacts

Hilary Touchett, PhD MSN BSN
Contact
hilary.touchett@va.gov
(713) 791-1414
Felicia Skelton, MD MS
Contact
Felicia.Skelton2@va.gov
(713) 794-7128
Hilary Touchett, PhD MSN BSN
principal investigator · Michael E. DeBakey VA Medical Center, Houston, TX

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion